• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II 2型受体-缓激肽B2型受体功能性异源二聚化

Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization.

作者信息

Abadir Peter M, Periasamy Ammasi, Carey Robert M, Siragy Helmy M

机构信息

Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, VA, USA.

出版信息

Hypertension. 2006 Aug;48(2):316-22. doi: 10.1161/01.HYP.0000228997.88162.a8. Epub 2006 Jun 5.

DOI:10.1161/01.HYP.0000228997.88162.a8
PMID:16754789
Abstract

Angiotensin II type 2 (AT2R) or bradykinin B2 (B2R) receptor activation enhances NO production. Recently, we demonstrated enhancement of NO production when AT2R and B2R are simultaneously activated in vivo. However, the mechanism involved in this enhancement is unknown. Using confocal fluorescence resonance energy transfer microscopy, we report the distance between the AT2R and B2R in PC12W cell membranes to be 50+/-5 A, providing evidence and quantification of receptor heterodimerization as the mechanism for enhancing NO production. The rate of AT2R-B2R heterodimer formation is largely a function of the degree of AT2R-B2R expression. The physical association between the dimerized receptors initiates changes in intracellular phosphoprotein signaling activities leading to phosphorylation of c-Jun terminal kinase, phosphotyrosine phosphatase, inhibitory protein kappaBalpha, and activating transcription factor 2; dephosphorylation of p38 and p42/44 mitogen-activated protein kinase and signal transducer inhibitor of transcription 3; and enhancing production of NO and cGMP. Controlling the expression of AT2R-B2R, consequently influencing their biologically active dimerization, presents a potential therapeutic target for the treatment of hypertension and other cardiovascular and renal disorders.

摘要

血管紧张素 II 2 型(AT2R)或缓激肽 B2(B2R)受体激活可增强一氧化氮(NO)的生成。最近,我们证明了在体内同时激活 AT2R 和 B2R 时,NO 的生成会增强。然而,这种增强所涉及的机制尚不清楚。利用共聚焦荧光共振能量转移显微镜,我们报告了 PC12W 细胞膜中 AT2R 和 B2R 之间的距离为 50±5 埃,为受体异二聚化作为增强 NO 生成的机制提供了证据和量化数据。AT2R - B2R 异二聚体形成的速率在很大程度上取决于 AT2R - B2R 的表达程度。二聚化受体之间的物理缔合引发细胞内磷酸化蛋白信号传导活性的变化,导致 c - Jun 末端激酶、磷酸酪氨酸磷酸酶、抑制蛋白κBα和激活转录因子 2 的磷酸化;p38 和 p42/44 丝裂原活化蛋白激酶以及转录信号转导抑制因子 3 的去磷酸化;以及增强 NO 和环磷酸鸟苷(cGMP)的生成。控制 AT2R - B2R 的表达,进而影响它们的生物活性二聚化,为治疗高血压及其他心血管和肾脏疾病提供了一个潜在的治疗靶点。

相似文献

1
Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization.血管紧张素II 2型受体-缓激肽B2型受体功能性异源二聚化
Hypertension. 2006 Aug;48(2):316-22. doi: 10.1161/01.HYP.0000228997.88162.a8. Epub 2006 Jun 5.
2
A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.可切割信号肽增强 Cerulean 标记的血管紧张素 II AT1 和缓激肽 B2 受体的细胞表面递呈和异二聚化。
Biochem Biophys Res Commun. 2011 Jun 10;409(3):544-9. doi: 10.1016/j.bbrc.2011.05.041. Epub 2011 May 11.
3
Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.腺病毒介导的猪心脏成纤维细胞中人类血管紧张素II 2型受体的过表达和刺激,不会调节细胞增殖、I型胶原蛋白mRNA表达及ERK1/ERK2活性,但会抑制蛋白酪氨酸磷酸酶。
J Mol Med (Berl). 2001 Sep;79(9):510-21. doi: 10.1007/s001090100243.
4
Novel signaling of dynorphin at κ-opioid receptor/bradykinin B2 receptor heterodimers.强啡肽在κ-阿片受体/缓激肽B2受体异二聚体上的新型信号传导。
Cell Signal. 2017 Feb;31:66-78. doi: 10.1016/j.cellsig.2017.01.005. Epub 2017 Jan 7.
5
Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.缓激肽B2受体与血管紧张素-(1-7) Mas受体之间的异源二聚化:功能后果
Hypertension. 2016 Oct;68(4):1039-48. doi: 10.1161/HYPERTENSIONAHA.116.07874. Epub 2016 Aug 22.
6
Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.血管损伤后血管紧张素II 2型受体的表达:血管紧张素转换酶抑制和血管紧张素受体阻断的不同作用
Hypertension. 2006 Nov;48(5):942-9. doi: 10.1161/01.HYP.0000241061.51003.b7. Epub 2006 Sep 18.
7
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?在COS-7细胞、HEK293细胞和NIH3T3细胞中缺乏血管紧张素Ⅱ1型受体(AT1R)/缓激肽2型受体(B2R)异源二聚体化的证据:AT1R/B2R异源二聚体有多常见?
J Biol Chem. 2009 Jan 16;284(3):1831-9. doi: 10.1074/jbc.M804607200. Epub 2008 Nov 18.
8
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.内源性核缓激肽B2受体在即刻早期基因激活中介导信号传导的表达。
J Cell Physiol. 2008 Jul;216(1):234-44. doi: 10.1002/jcp.21398.
9
Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.血管加压素遇见血管舒张素:AT1-B2 受体异二聚体。
Biochem Pharmacol. 2014 Apr 1;88(3):284-90. doi: 10.1016/j.bcp.2014.01.019. Epub 2014 Jan 22.
10
Activity of Bradykinin B2 Receptor Is Regulated by Long-Chain Polyunsaturated Fatty Acids.缓激肽B2受体的活性受长链多不饱和脂肪酸调控。
PLoS One. 2013 Jun 27;8(6):e68151. doi: 10.1371/journal.pone.0068151. Print 2013.

引用本文的文献

1
GPCR dimerization: Drug discovery aspects and targets in renin-angiotensin systems.G蛋白偶联受体二聚化:肾素-血管紧张素系统中的药物发现方面及靶点
FASEB Bioadv. 2025 Jan 31;7(3):e1486. doi: 10.1096/fba.2024-00180. eCollection 2025 Mar.
2
Cross-Section of Hypertensive Molecular Signaling Pathways: Understanding Pathogenesis and Identifying Improved Drug Targets.高血压分子信号通路的横断面:理解发病机制与确定改进的药物靶点
Curr Hypertens Rev. 2025;21(1):31-44. doi: 10.2174/0115734021342501250107052350.
3
Gestational Intermittent Hypoxia Impairs ATR-Mediated Vascular Protection in Female Offspring on a High-Fat, High-Sucrose Diet.
孕期间歇性低氧会损害高脂高糖饮食的雌性后代中ATR介导的血管保护作用。
J Biotechnol Biomed. 2024;7(2):264-276. doi: 10.26502/jbb.2642-91280150. Epub 2024 Jun 14.
4
The possible mechanism and research progress of ACE2 involved in cardiovascular injury caused by COVID-19: a review.血管紧张素转换酶2(ACE2)参与新型冠状病毒肺炎(COVID-19)所致心血管损伤的可能机制及研究进展:综述
Front Cardiovasc Med. 2024 May 27;11:1409723. doi: 10.3389/fcvm.2024.1409723. eCollection 2024.
5
Is there a role for bradykinin in cerebral malaria pathogenesis?缓激肽在脑型疟疾发病机制中是否起作用?
Front Cell Infect Microbiol. 2023 Aug 10;13:1184896. doi: 10.3389/fcimb.2023.1184896. eCollection 2023.
6
The AT/AT Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System.血管紧张素原/血管紧张素受体平衡是肾素-血管紧张素系统调节的基石,不仅局限于心血管系统。
Molecules. 2023 Jul 18;28(14):5481. doi: 10.3390/molecules28145481.
7
Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.血管紧张素转化酶与高血压:各类血管紧张素转化酶抑制剂的系统性分析、它们的副作用,以及作为高血压潜在治疗方法的生物活性肽。
J Renin Angiotensin Aldosterone Syst. 2023 Jun 21;2023:7890188. doi: 10.1155/2023/7890188. eCollection 2023.
8
Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil.肌球蛋白激活剂 Omecamtiv Mecarbil 诱导的左心室大鼠基因表达改变。
Genes (Basel). 2023 Jan 1;14(1):122. doi: 10.3390/genes14010122.
9
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.高血压的代偿性肾素-血管紧张素系统:COVID-19 大流行时代的回顾与更新。
Biochem Pharmacol. 2023 Feb;208:115370. doi: 10.1016/j.bcp.2022.115370. Epub 2022 Dec 5.
10
CGP42112: the full AT2 receptor agonist and its role in the renin-angiotensin-aldosterone system: no longer misunderstood.CGP42112:全 AT2 受体激动剂及其在肾素-血管紧张素-醛固酮系统中的作用:不再被误解。
Clin Sci (Lond). 2022 Nov 11;136(21):1513-1533. doi: 10.1042/CS20220261.